Satellos Bioscience Inc. (MSLE)
| Market Cap | 190.92M +126.2% |
| Revenue (ttm) | n/a |
| Net Income | -34.61M |
| EPS | -1.99 |
| Shares Out | 21.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,690 |
| Open | 9.13 |
| Previous Close | 9.08 |
| Day's Range | 8.95 - 9.25 |
| 52-Week Range | 5.30 - 13.40 |
| Beta | 1.17 |
| Analysts | Strong Buy |
| Price Target | 26.25 (+192.64%) |
| Earnings Date | Aug 13, 2026 |
About MSLE
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for MSLE stock is "Strong Buy." The 12-month stock price target is $26.25, which is an increase of 192.64% from the latest price.
News
Satellos to Participate in Upcoming Investor Conferences
Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management...
Satellos to Participate in Upcoming Investor Conferences
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative musc...
Satellos initiated with an Outperform at LifeSci Capital
LifeSci Capital initiated coverage of Satellos (MSLE) with an Outperform rating and $22 price target
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.
Satellos Bioscience Registration statement
Satellos Bioscience filed a registration statement on August 22, 2026, providing details about a securities offering with the SEC.